Export 246 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is W  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Traquete, R., & Wallace, H. M. (2012). Developing vector systems: Targeting tumours. Biochemist, 34(1), 22 - 25.
Howes, A., Taubert, C., Blankley, S., Spink, N., et al. (2016). Differential production of Type I IFN Determines the Reciprocal Levels of IL-10 and proinflammatory cytokines produced by C57BL/6 and BALB/c macrophages. Journal of Immunology, 197(7), 2838 - 2853.
Mota, R., Pereira, S. B., Meazzini, M., Fernandes, R., et al. (2015). Differential proteomes of the cyanobacterium Cyanothece sp. CCY 0110 upon exposure to heavy metals. Data in Brief, 4, 152 - 158.
Piovesan, D., Tabaro, F., Mičetić, I., Necci, M., et al. (2017). DisProt 7.0: A major update of the database of disordered proteins. Nucleic Acids Research, 45(D1), D219 - D227.
Bettencourt, C., Hensman-Moss, D., Flower, M., Wiethoff, S., et al. (2016). DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. Annals of Neurology, 79(6), 983 - 990.
Bettencourt, C., Hensman-Moss, D., Flower, M., Wiethoff, S., et al. (2016). DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. Annals of Neurology, 79(6), 983 - 990.
Weber, E. M., Hultgren, J., Algers, B., & Olsson, I. A. S. (2016). Do laboratory mouse females that lose their litters behave differently around parturition?. PLoS ONE, 11(8).
Lopes, C. S., Sampaio, P., Williams, B., Goldberg, M., & Sunkel, C. E. (2005). The Drosophila Bub3 protein is required for the mitotic checkpoint and for normal accumulation of cyclins during G2 and early stages of mitosis. Journal of Cell Science, 118(1), 187 - 198.
Colombié, N., Vérollet, C., Sampaio, P., Moisand, A., et al. (2006). The Drosophila γ-tubulin small complex subunit Dgrip84 is required for structural and functional integrity of the spindle apparatus. Molecular Biology of the Cell, 17(1), 272 - 282.
Rodrigues, P. N. S., Vázquez-Dorado, S., Neves, J. V., & Wilson, J. M. (2006). Dual function of fish hepcidin: Response to experimental iron overload and bacterial infection in sea bass (Dicentrarchus labrax). Developmental and Comparative Immunology, 30(12), 1156 - 1167.
Martins, I., Pinto, M., Wilson, S. P., Lima, D., & Tavares, I. (2008). Dynamic of migration of HSV-1 from a medullary pronociceptive centre: Antinociception by overexpression of the preproenkephalin transgene. European Journal of Neuroscience, 28(10), 2075 - 2083.
E
Vaz-Da-Silva, M., Loureiro, A. I., Falcao, A., Nunes, T., et al. (2008). Effect of food on the pharmacokinetic profile of trans-resveratrol. International Journal of Clinical Pharmacology and Therapeutics, 46(11), 564 - 570.
Mota, R., Pereira, S. B., Meazzini, M., Fernandes, R., et al. (2015). Effects of heavy metals on Cyanothece sp. CCY 0110 growth, extracellular polymeric substances (EPS) production, ultrastructure and protein profiles. Journal of Proteomics, 120, 75 - 94.
Cunha, V., Burkhardt-Medicke, K., Wellner, P., Santos, M. M., et al. (2017). Effects of pharmaceuticals and personal care products (PPCPs) on multixenobiotic resistance (MXR) related efflux transporter activity in zebrafish (Danio rerio) embryos. Ecotoxicology and Environmental Safety, 136, 14 - 23.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Kramer, G., Wegdam, W., Donker-Koopman, W., Ottenhoff, R., et al. (2016). Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models. FEBS Open Bio, 6(9), 902 - 913.
Moraes, C. B., White, K. L., Braillard, S., Perez, C., et al. (2015). Enantiomers of nifurtimox do not exhibit stereoselective anti-Trypanosoma cruzi activity, toxicity, or pharmacokinetic properties. Antimicrobial Agents and Chemotherapy, 59(6), 3645 - 3647.
Barata, L., Sousa Silva, M., Schuldt, L., Ferreira, A. E. N., et al. (2011). Enlightening the molecular basis of trypanothione specificity in trypanosomatids: Mutagenesis of Leishmania infantum glyoxalase II. Experimental Parasitology, 129(4), 402 - 408.
Harmatz, P., Giugliani, R., Schwartz, I., Guffon, N., et al. (2006). Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-l. Journal of Pediatrics, 148(4), 533 - 533.e.
Harmatz, P., Giugliani, R., Schwartz, I., Guffon, N., et al. (2006). Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-l. Journal of Pediatrics, 148(4), 533 - 533.e.
Harmatz, P., Yu, Z. - F., Giugliani, R., Schwartz, I. V. D., et al. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of Inherited Metabolic Disease, 33(1), 51 - 60.
Harmatz, P., Yu, Z. - F., Giugliani, R., Schwartz, I. V. D., et al. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of Inherited Metabolic Disease, 33(1), 51 - 60.
Decker, C., Yu, Z. - F., Giugliani, R., Schwartz, I. V. D., et al. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of Pediatric Rehabilitation Medicine, 3(2), 89 - 100.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc